BamSEC and AlphaSense Join Forces
Learn More

ImmunityBio Inc. – Transcripts

NASDAQ: IBRX    
Share price (8/21/26): $7.79    
Market cap (8/21/26): $8.256 billion
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Earnings Revised 03/18/26 ImmunityBio, Inc., 2025 Earnings Call, Mar 03, 2026 03/03/26
Other Revised 01/19/26 ImmunityBio, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 01/11/26
CY 2025
Other Revised 07/16/25 ImmunityBio, Inc. - Analyst/Investor Day 04/15/25
CY 2024
Other Revised 04/26/24 ImmunityBio, Inc. - Special Call 04/26/24
CY 2023
Other Revised 10/03/25 ImmunityBio, Inc. - Special Call 09/21/23
CY 2021
Other Revised 01/13/21 NantKwest, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 05:20 AM 01/13/21
CY 2020
Other Revised 12/21/20 ImmunityBio, Inc., NantKwest, Inc. - M&A Call 12/21/20
Other Revised 05/27/20 NantKwest, Inc. - Special Call 05/27/20
Other Revised 01/14/20 NantKwest, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-14-2020 11:00 AM 01/14/20
CY 2019
Other Revised 12/02/19 NantKwest, Inc. - Special Call 12/02/19
Other Revised 01/08/19 NantKwest, Inc. - Analyst/Investor Day 01/08/19
CY 2018
Other Revised 01/09/18 NantKwest, Inc. - Analyst/Investor Day 01/09/18